POPS RICHARD F 4

Accession 0001127602-24-007137

CIK 0001520262other

View on SEC.gov Company Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 4:02 PM ET

Size

37.1 KB

Accession

0001127602-24-007137

Insider Transaction Report

Form 4

Period: 2024-02-26

Alkermes plc.ALKS

POPS RICHARD F

DirectorDirector and CEO, Alkermes plc

Transactions

Other
Employee Stock Option (Right to Buy)
2023-11-17$31.64/sh+5,999$189,808→ 305,999 total
Exercise: $31.64Exp: 2026-02-28→ Ordinary Shares (5,999 underlying)
Other
Employee Stock Option (Right to Buy)
2023-11-17$65.94/sh+5,899$388,980→ 300,899 total
Exercise: $65.94Exp: 2028-02-16→ Ordinary Shares (5,899 underlying)
Award
Employee Stock Option (Right to Buy)
2024-02-26+274,328→ 274,328 total
Exercise: $30.04Exp: 2034-02-26→ Ordinary Shares (274,328 underlying)
Other
Employee Stock Option (Right to Buy)
2023-11-17$46.24/sh+4,599$212,658→ 234,599 total
Exercise: $46.24Exp: 2024-03-03→ Ordinary Shares (4,599 underlying)
Other
Employee Stock Option (Right to Buy)
2023-11-17$20.03/sh+7,168$143,575→ 365,634 total
Exercise: $20.03Exp: 2030-02-20→ Ordinary Shares (7,168 underlying)
Other
Employee Stock Option (Right to Buy)
2023-11-17$19.34/sh+6,843$132,344→ 349,030 total
Exercise: $19.34Exp: 2031-02-22→ Ordinary Shares (6,843 underlying)
Other
Employee Stock Option (Right to Buy)
2023-11-17$69.83/sh+3,999$279,250→ 203,999 total
Exercise: $69.83Exp: 2025-02-26→ Ordinary Shares (3,999 underlying)
Other
Employee Stock Option (Right to Buy)
2023-11-17$53.50/sh+3,999$213,947→ 203,999 total
Exercise: $53.50Exp: 2027-02-17→ Ordinary Shares (3,999 underlying)
Other
Employee Stock Option (Right to Buy)
2023-11-17$31.93/sh+2,419$77,239→ 123,419 total
Exercise: $31.93Exp: 2029-02-21→ Ordinary Shares (2,419 underlying)
Other
Employee Stock Option (Right to Buy)
2023-11-17$31.93/sh+7,644$244,073→ 389,844 total
Exercise: $31.93Exp: 2029-02-21→ Ordinary Shares (7,644 underlying)
Other
Employee Stock Option (Right to Buy)
2023-11-17$24.59/sh+5,980$147,048→ 305,024 total
Exercise: $24.59Exp: 2032-02-18→ Ordinary Shares (5,980 underlying)
Other
Employee Stock Option (Right to Buy)
2023-11-17$26.82/sh+5,697$152,794→ 290,570 total
Exercise: $26.82Exp: 2033-02-23→ Ordinary Shares (5,697 underlying)

Footnotes (8)

[F1]Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5.
[F2]These options are fully vested in accordance with their terms.
[F3]Shares underlying the stock option award shall not vest and become exercisable unless and until the closing price of an ordinary share of Alkermes plc, as reported by the Nasdaq Global Select Market or another national securities exchange on which Alkermes plc's ordinary shares are listed, is fifty U.S. Dollars (US$50.00) or higher for thirty (30) consecutive trading days during the term of the award (the "performance criteria"). Subject to achievement of the performance criteria, the shares underlying the stock option award shall vest in four equal annual installments commencing on 2/21/2020. This award expires ten years from the date of grant.
[F4]Shares subject to the stock option award vest and become exercisable in four equal annual installments commencing on 2/20/2021.
[F5]Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022.
[F6]Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023.
[F7]Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024.
[F8]Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025.

Documents

2 files

Issuer

Alkermes plc.

CIK 0001520262

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001126490

Filing Metadata

Form type: 4
Filed: Feb 26, 7:00 PM ET
Accepted: Feb 27, 4:02 PM ET
Size: 37.1 KB

View on SEC.gov